Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Diluted EPS of $0.67 per share (loss) for fiscal year 2023.
Harvard Apparatus Regenerative Technology, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.67 | -21.8% |
| 2022 | -$0.55 | +30.4% |
| 2021 | -$0.79 | -43.6% |
| 2020 | -$0.55 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$0.12 | +0.0% | +33.3% |
| June 30, 2024 | -$0.18 | +5.3% | -20.0% |
| March 31, 2024 | -$0.15 | +37.5% | -25.0% |
| September 30, 2023 | -$0.12 | -20.0% | +36.8% |
| June 30, 2023 | -$0.19 | -58.3% | +20.8% |
| March 31, 2023 | -$0.24 | -20.0% | -140.0% |
| September 30, 2022 | -$0.10 | -25.0% | +16.7% |
| June 30, 2022 | -$0.12 | -200.0% | +40.0% |
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -21.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2023 period, Harvard Apparatus Regenerative Technology, Inc.’s diluted eps has declined by 21.8% (from $0.55 per share (loss) to $0.67 per share (loss)).
- The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: